Cancer antigen 125 (CA-125) is a standard tumour biomarker used to diagnose epithelial ovarian cancer and monitor women who have been diagnosed with epithelial ovarian cancer during or after therapy. The gene discussed is MUC16; the disease is ovarian carcinoma.